{
    "id": 3457,
    "name": "invasive lobular carcinoma",
    "source": "DOID",
    "definition": "A breast lobular carcinoma that is characterized by infiltration into the tissue of the breast outside of the lobule where it originated. [url:http\\://www.breastcancer.org/symptoms/types/ilc, url:https\\://www.ncbi.nlm.nih.gov/pubmed/25849106]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:3457",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02206984",
            "title": "Endocrine Response in Women With Invasive Lobular Breast Cancer",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 1456,
                    "therapyName": "Tamoxifen",
                    "synonyms": null
                },
                {
                    "id": 633,
                    "therapyName": "Anastrozole",
                    "synonyms": null
                },
                {
                    "id": 744,
                    "therapyName": "Fulvestrant",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03596073",
            "title": "Topical Calcipotriene Treatment for Breast Cancer Immunoprevention",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 3695,
                    "therapyName": "calcipotriene",
                    "synonyms": null
                }
            ]
        }
    ]
}